Workflow
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
Globenewswire· 2025-06-13 14:30
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces that dosing has commenced at the prestigious Weill Cornell Medicine Multiple Sclerosis Center in New York City, in its ongoing Phase 2 clinical trial evaluating intranasal foralumab in patients with n ...
REDCLOUD TO PARTICIPATE AT THE ROTH 15th ANNUAL LONDON CONFERENCE
Globenewswire· 2025-06-13 13:35
Company Overview - RedCloud Holdings plc operates a trading platform that facilitates the trade of fast-moving consumer goods (FMCG) across business supply chains, addressing the challenge of accessing key purchase and sales data between brands, distributors, and retailers in high-growth consumer markets [4] - The platform leverages artificial intelligence (AI) to provide data-driven insights, enabling retailers to make faster and more informed business-to-business (B2B) purchasing and inventory decisions [4] Event Participation - Justin Floyd, CEO and Co-Founder of RedCloud, will attend the ROTH 15 Annual London Conference, scheduled for June 24-26, 2025, at the Four Seasons Hotel London [1][2] - The conference format includes 1-on-1 and small group meetings, allowing institutional investors to engage with executive management from approximately 70 companies across various sectors [2] About ROTH - ROTH is a relationship-driven investment bank that focuses on serving growth companies and their investors, offering a full-service platform that includes capital raising, equity research, macroeconomics, sales and trading, and M&A advisory [3]
Regarding the investment in the share capital of UAB "Ateities ūkis"
Globenewswire· 2025-06-13 13:26
In order to promote the production of raw milk in Lithuania, AB "Rokiškio sūris" has invested EUR 10 million in to the authorized capital of UAB "Ateities ūkis" by acquiring 29.67 per cent of the authorized capital. UAB "Ateities ūkis" is a company belonging to the Agrokoncernas group, one of the main activities of which is the production of raw milk. In the opinion of the management of AB Rokiškio sūris, this transaction is beneficial for the company, as it will ensure an increase in the production of high ...
NFI Announces Completion of $600 million Second Lien Notes Offering
Globenewswire· 2025-06-13 13:20
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES WINNIPEG, Manitoba, June 13, 2025 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI, or the Company) a leader in propulsion-agnostic bus and coach mobility solutions, today announced that its subsidiary, New Flyer Holdings, Inc. (the Issuer), has completed its previously announced private offering of $600 million in aggregate principal amount of 9.250% second lien senior secured notes due 2030 (th ...
Multi Ways Holdings Files Annual Report on Form 20-F for Fiscal Year 2024
Globenewswire· 2025-06-13 13:15
SINGAPORE, June 13, 2025 (GLOBE NEWSWIRE) -- Multi Ways Holdings Limited (“Multi Ways,” the “Company” or the “Issuer”) (NYSE American: MWG), a leading supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region, announced that it has filed its annual report on Form 20-F, including its financial results, for the fiscal year ended December 31, 2024 (the “2024 Annual Report”) with the U.S. Securities and Exchange Commission. The 2024 Annual Report can b ...
Millicom (Tigo) Announces Partial Closing of Infrastructure Deal with SBA and Intention to Declare a Special Dividend of $2.50 per Share Representing Around 45% of the Proceeds
Globenewswire· 2025-06-13 13:00
Millicom (Tigo) Announces Partial Closing of Infrastructure Deal with SBA and Intention to Declare a Special Dividend of $2.50 per Share Representing Around 45% of the Proceeds Luxembourg, June 13, 2025 – Millicom International Cellular S.A. (NASDAQ: TIGO) today announced the partial closing of its previously disclosed transaction with SBA Communications Corporation (NASDAQ: SBAC), through the sale of LATI International S.A., the Luxembourg-based holding company for Millicom’s mobile passive infrastructure ...
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
Globenewswire· 2025-06-13 13:00
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that a 1-for-8 reverse stock split of its outstanding shares of common stock will be effective at 11:59 pm Eastern Time June 16, 2025. Following the reverse stock split, the Compan ...
Le Mans Ultimate to Launch Full 1.0 Release on July 22, 2025, Introducing Mercedes AMG LMGT3 Evo, Aston Martin Valkyrie, and a Glimpse Into the Future
Globenewswire· 2025-06-13 13:00
Le Mans Ultimate to Launch Full 1.0 Release on July 22, 2025, Introducing Mercedes AMG LMGT3 Evo, Aston Martin Valkyrie, and a Glimpse Into the Future Le Mans Ultimate is set to be full released on 22nd July 2025, including the Aston Martin Valkyrie AMR and the Mercedes AMG LMGT3 Evo. Additionally, the European Le Mans Series content is confirmed for the title as well as future plans for a career mode. MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or “ ...
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
Globenewswire· 2025-06-13 13:00
– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 asthma – – Data supports ongoing Phase 2 acute exacerbation studies in asthma and COPD; expect to report topline data from both studies in 1H26 – SAN DIEGO, June 13, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stag ...
Cloudastructure Partners with Leading National Property Management Firm to Protect High-Profile Mixed-Use Community
Globenewswire· 2025-06-13 13:00
PALO ALTO, CA, June 13, 2025 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”) a recognized leader in AI surveillance and remote guarding solutions, today announced that a leading national property management firm, with assets across 18 states, has selected the Company’s advanced AI Surveillance platform to enhance security at a prominent mixed-use community. The decision aims to address persistent security challenges affecting both residents an ...